MultiCell Technologies, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MultiCell Technologies, Inc.

MCET 0.00001000

0.0%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Shawn Donahue who wrote (116)	11/17/2005 2:06:54 AM
From: EACarl	of 237

RE "MultiCell ImmunoTherapeutics, has elevated MCT-465 to lead drug candidate status and will commence evaluation of MCT-465 in preclinical animal models" Thanks for posting that Shawn. It makes the point at how desperate the poor management at MUCKLE is getting. Tossing out a PR relating to the current "hot" flu subject. Unfortunately, even that is getting the result of lower and lower highs for the pps. Their almost out of cash (AGAIN), and the share price is near 2 year lows making for another horrific dilution likely on the way. STILL NOTHING has entered phase I, and the only decent contract they had isn't even being paid the minimum payments to them! All in all a terrible stock. MUCKLE has been the "Murphy" of stocks - anything that could go wrong, did go wrong. The only thing sadder, is some of you guys not wanting to admit it. Hows that AMEX listing going? - NOT! How'd that REVERSE split do for you? - NOT! How'd all that wasted money of paid coverage help? - NOT.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next